Submitted by Anonymous (not verified) on 20 September 2024 - 8:42
Human medicines European public assessment report (EPAR): Imbruvica, ibrutinib, Date of authorisation: 21/10/2014, Revision: 34, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Imbruvica, ibrutinib, Date of authorisation: 21/10/2014, Revision: 34, Status: Authorised